BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33481164)

  • 1. Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets.
    Lin Z; Liu Y; Chen L; Cao S; Huang Y; Yang X; Zhu F; Tang W; He S; Zuo J
    Sci China Life Sci; 2021 Oct; 64(10):1702-1719. PubMed ID: 33481164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
    Wu Y; He S; Bai B; Zhang L; Xue L; Lin Z; Yang X; Zhu F; He P; Tang W; Zuo J
    Cell Mol Immunol; 2016 May; 13(3):379-90. PubMed ID: 25942599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.
    Erre GL; Bosincu L; Faedda R; Fenu P; Masala A; Sanna M; Taras L; Longu MG; Piras M; Soro G; Satta AE; Passiu G
    Rheumatol Int; 2014 Apr; 34(4):535-41. PubMed ID: 24232504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features.
    Lopez-Pedrera C; Patiño-Trives AM; Cerdó T; Ortega-Castro R; Sanchez-Pareja I; Ibañez-Costa A; Muñoz-Barrera L; Ábalos-Aguilera MC; Ruiz-Vilchez D; Seguí Azpilcueta P; Espinosa M; Barbarroja N; Escudero-Contreras A; Castaño JP; Luque RM; Ortega R; Aguirre MA; Perez-Sanchez C
    J Autoimmun; 2023 Feb; 135():102990. PubMed ID: 36621176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses.
    Hou LF; He SJ; Li X; Yang Y; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP
    Arthritis Rheum; 2011 Aug; 63(8):2445-55. PubMed ID: 21484768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxifolin inhibits NETosis through activation of Nrf2 and provides protective effects in models of lupus and antiphospholipid syndrome.
    Rysenga CE; May-Zhang L; Zahavi M; Knight JS; Ali RA
    Rheumatology (Oxford); 2024 Jul; 63(7):2006-2015. PubMed ID: 37815837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2/HO-1 in myeloid-derived suppressor cells.
    Li D; Shi G; Wang J; Zhang D; Pan Y; Dou H; Hou Y
    Arthritis Res Ther; 2019 Apr; 21(1):105. PubMed ID: 31023362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nrf2 suppresses lupus nephritis through inhibition of oxidative injury and the NF-κB-mediated inflammatory response.
    Jiang T; Tian F; Zheng H; Whitman SA; Lin Y; Zhang Z; Zhang N; Zhang DD
    Kidney Int; 2014 Feb; 85(2):333-343. PubMed ID: 24025640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.
    Hou LF; He SJ; Li X; Wan CP; Yang Y; Zhang XH; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP
    PLoS One; 2012; 7(2):e32424. PubMed ID: 22389703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
    Zdrojewski Z
    Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus.
    Daugas E; Nochy D; Huong DLT; Duhaut P; Beaufils H; Caudwell V; Bariety J; Piette JC; Hill G
    J Am Soc Nephrol; 2002 Jan; 13(1):42-52. PubMed ID: 11752020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms.
    Tong X; Chen L; He SJ; Zuo JP
    Acta Pharmacol Sin; 2022 Dec; 43(12):3055-3061. PubMed ID: 36050518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Lupus Erythematosus and Antiphospholipid Syndrome-The Double Trouble.
    Londhey V
    J Assoc Physicians India; 2017 Mar; 65(3):11-12. PubMed ID: 28462537
    [No Abstract]   [Full Text] [Related]  

  • 15. 4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients.
    Tang C; Wang X; Xie Y; Cai X; Yu N; Hu Y; Zheng Z
    Cell Physiol Biochem; 2018; 51(2):979-990. PubMed ID: 30466076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinins-a Promising New Treatment for Systemic Lupus Erythematosus: a Descriptive Review.
    Mu X; Wang C
    Curr Rheumatol Rep; 2018 Jul; 20(9):55. PubMed ID: 30056574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta2-glycoprotein I Expression in Lupus Nephritis Patients with Antiphospholipid-associated Nephropathy.
    Gao R; Yu W; Wen Y; Li H
    J Rheumatol; 2016 Nov; 43(11):2026-2032. PubMed ID: 27633824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages.
    Yan YX; Shao MJ; Qi Q; Xu YS; Yang XQ; Zhu FH; He SJ; He PL; Feng CL; Wu YW; Li H; Tang W; Zuo JP
    Acta Pharmacol Sin; 2018 Oct; 39(10):1633-1644. PubMed ID: 29849131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.